Ciprofloxacin-induced microbiota dysbiosis triggers seizure susceptibility through the microbiota-gut-brain axis

Qihang Zou1,2, Yaqian Zhang1, Shangnan Zou1,3

  • 1Clinical Neuroscience Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.

Abstract

Insights

Gut microbiota disruption increases seizure risk by causing inflammation and damaging barriers. Fecal microbiota transplantation (FMT) can restore gut health, reduce inflammation, and decrease seizure susceptibility in rats.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • Epilepsy is associated with inflammation and gut microbiota dysbiosis.
  • Disruption of gut microbiota by ciprofloxacin may heighten seizure susceptibility.
  • This study explores the mechanisms and therapeutic potential of fecal microbiota transplantation (FMT) for fluoroquinolone-induced seizures.

Purpose of the Study:

  • Investigate the link between gut microbiota dysbiosis and seizure susceptibility.
  • Elucidate the role of intestinal and blood-brain barrier (BBB) integrity in neuroinflammation.
  • Evaluate the efficacy of FMT in mitigating seizure susceptibility and associated pathologies.

Main Methods:

  • Utilized a rat model with ciprofloxacin-induced gut dysbiosis.
  • Administered FMT or phosphate-buffered saline (PBS) to assess therapeutic effects.
  • Assessed seizure susceptibility via pentylenetetrazole (PTZ) challenge and analyzed gut/BBB integrity, neuroinflammation, and cortical gene expression.

Main Results:

  • Ciprofloxacin-induced dysbiosis increased seizure susceptibility, gut and BBB dysfunction, and neuroinflammation.
  • Reduced microbial diversity and depletion of specific taxa correlated with intestinal barrier defects.
  • FMT treatment restored microbial diversity, improved barrier function, reduced neuroinflammation, and decreased seizure susceptibility.

Conclusions:

  • Gut microbiota dysbiosis contributes to seizure susceptibility via neuroinflammatory pathways.
  • This research highlights the gut-brain axis's role in fluoroquinolone-induced seizures.
  • Fecal microbiota transplantation shows promise as a therapeutic strategy for managing seizures linked to gut dysbiosis.

Related Concept Videos

Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
125
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
93
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
563
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
94